The Semaglutide Treatment Effect in People With Obesity (STEP) trials have shown the efficacy of semaglutide for the treatment of obesity
48,56,57 For SGLT-2 inhibitors, the major completed CVOTs including empagliflozin in the Cardiovascular Outcome Event Trial in Type 2 Diabetes Mellitus Patients [EMPA-REG OUTCOME], canagliflozin in the Canagliflozin Cardiovascular Assessment Study [CANVAS Program], and dapagliflozin in the Dapagliflozin Effect on Cardiovascular EventsThrombolysis in Myocardial Infarction 58 [DECLARE-TIMI 58] trial
As well as Camden, Gloucester, Burlington, Salem, Cumberland, and Atlantic Counties in South Jersey, plus nearby communities like Vineland, Margate, Cape May, and even Wilmington, Delaware
Studies have consistently shown that tirzepatide can provide more weight loss than single-agonist GLP-1 drugs like semaglutide (Ozempic and Wegovy), ranging around 20% lost weight over a years time on average
Additional oral or sublingual B12 supplementation is generally safe alongside the blend, though likely unnecessary for most patients since the injection provides direct B12 delivery
Plan on a couple of weeks of administrative setup before your first submission